Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a leader in veterinary diagnostics and software, has been navigating a complex market landscape characterized by fluctuating veterinary visit trends and ...
Fatty infiltration of the pancreas (FIP) has been recognized for nearly a century, yet many aspects of this condition remain unclear. Regular literature reviews on the diagnosis, consequences, and ...
It’s the first time I’ve worn a suit in four years,” Smiley said. “We haven’t worn suits in four years, since post COVID, so it’s kind of fun to say ...